CADL
Candel TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CADL vs peer average
51/100
CADL vs. peer average (C vs. C)
Grade spread
A 1 · B 3 · C 1 · D 6
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ACRS is the first available peer comparator.
Aclaris is a loose small-cap biotech peer that is useful mainly for comparing clinical-timeline and financing sensitivity rather than mechanism or commercial setup.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CADL
Candel Therapeutics
ACRS
Aclaris Therapeutics
Grade
C
D
Momentum
87
88
Value
41
41
Sentiment
34
26
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs ACRS
CADL / ACRS
Grade Position
In line
CADL vs. peer average (C vs. C)
51/100
Momentum
87
ACRSValue
41
CADLSentiment
34
CADLRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CADL
ACRS is the first peer returned for this comparison set.